tdp2664
InvestorPlace
Companies like BioMarin Pharmaceutical are cashing in on rare diseases, where they can charge hundreds of thousands of dollars every year for their drugs.
Everything You Want!
Wednesday February 22nd 2012
tdp2664
InvestorPlace
Companies like BioMarin Pharmaceutical are cashing in on rare diseases, where they can charge hundreds of thousands of dollars every year for their drugs.
